Evidence map›Paper›PMID 33733369›Full record

ArticleCell biochemistry and biophysics2021

Terminal Peptide Extensions Augment the Retinal IMPDH1 Catalytic Activity and Attenuate the ATP-induced Fibrillation Events.

Behnaz Andashti, Razieh Yazdanparast, Maede Motahar, Ebrahim Barzegari, Hamid Galehdari

Abstract read
PubMed Publisher
In one paragraph

Article in Cell biochemistry and biophysics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Novel VariantInternational journal of molecular sciences · 2023
    Article
  6. Article
  7. The gateway to guanine nucleotides: Allosteric regulation of IMP dehydrogenases.Protein science : a publication of the Protein Society · 2022
    Review
  8. IMPDH dysregulation in disease: a mini review.Biochemical Society transactions · 2022
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Behnaz AndashtiInstitute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.
Razieh YazdanparastInstitute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran. ryazdan@ut.ac.ir.ORCID http://orcid.org/0000-0003-4441-6975
Maede MotaharInstitute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.
Ebrahim BarzegariInstitute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.
Hamid GalehdariDepartment of Biology, Faculty of Science, Shahid Chamran University of Ahvaz, Ahvaz, Iran.
University of Tehran · IRShahid Chamran University of Ahvaz · IR

Funding

Research Council of University of Tehran 123456
6 · The paper itself

Abstract

Defects in inosine monophosphate dehydrogenase-1 (IMPDH1) lead to insufficient biosyntheses of purine nucleotides. In eyes, these defects are believed to cause retinitis pigmentosa (RP). Major retinal isoforms of IMPDH1 are structurally distinct from those in other tissues, by bearing terminal extensions. Using recombinant mouse IMPDH1 (mH1), we evaluated the kinetics and oligomerization states of the retinal isoforms. Moreover, we adopted molecular simulation tools to study the possible effect of terminal tails on the function of major enzyme isoforms with the aim to find structural evidence in favor of contradictory observations on retinal IMPDH1 function. Our findings indicated higher catalytic activity for the major mouse retinal isoform (mH1603) along with lower fibrillation capacity under the influence of ATP. However, higher mass oligomerization products were formed by the mH1 (603) isoform in the presence of the enzyme inhibitors such as GTP and/or MPA. Collectively, our findings demonstrate that the structural differences between the retinal isoforms have led to functional variations possibly to justify the retinal cells' requirements.

Indexed as

Adenosine TriphosphateAnimalsGuanosine TriphosphateHumansHydrogen BondingIMP DehydrogenaseKineticsMiceProtein IsoformsProtein MultimerizationProtein Structure, QuaternaryRecombinant ProteinsRetinaAdenosine TriphosphateGuanosine TriphosphateIMP DehydrogenaseIMPDH1, mouseIMPDH1 protein, humanProtein IsoformsRecombinant ProteinsCatalytic activityIMPDH1Retinal isoformRetinitis PigmentosaTerminal tail

Identifiers

PMID33733369
OpenAlexW3138481357

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.